US High Court Rejects Allergan's Sanctura Patent Appeal

15.10.2012 - The U.S. Supreme Court on Monday rejected Allergans appeal of a ruling that favored generic drugmaker Watson Pharmaceuticals over patents related to the treatment of an overactive...